» Articles » PMID: 37691097

Association Between Weight-adjusted-waist Index and Chronic Kidney Disease: a Cross-sectional Study

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2023 Sep 10
PMID 37691097
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We aimed to investigate the potential association between weight-adjusted-waist index (WWI) and chronic kidney disease (CKD).

Design And Methods: This research examined data collected from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2020. CKD was defined as the low estimated glomerular filtration rate (eGFR) or the existence of albuminuria (urinary albumin-to-creatinine ratio (ACR) ≥ 30mg/g). Low-eGFR was described as eGFR < 60 mL/min/1.73m. The associations between WWI with CKD, albuminuria, and low-eGFR were examined using generalized additive models and weighted multivariable logistic regression models. We also analyzed the associations of other obesity indicators with CKD, albuminuria, and low-eGFR, including body mass index (BMI), waist-to-height ratio (WHtR), waist circumference(WC), height, and weight. The receiver operating characteristic (ROC) curves were used to assess and compare their diagnostic abilities.

Results: Males made up 48.26% of the total 40,421 individuals that were recruited. The prevalences of CKD, albuminuria, and low-eGFR were 16.71%, 10.97%, and 7.63%, respectively. WWI was found to be positively linked with CKD (OR = 1.42; 95% CI: 1.26, 1.60). A nonlinear connection between WWI and CKD was found using smooth curve fitting. Additionally, a higher prevalence of albuminuria is linked to a higher level of WWI (OR = 1.60; 95% CI: 1.40, 1.82). Different stratifications did not substantially influence the connection between WWI and CKD, albuminuria, and low-eGFR, according to subgroup analysis and interaction tests. We observed higher height was related to higher low-eGFR prevalence (OR = 1.05; 95% CI: 1.03, 1.06). ROC analysis revealed that WWI had the best discrimination and accuracy for predicting CKD and albuminuria compared to other obesity indicators (BMI, WHTR, WC, height and weight). In addition, height had the highest area under the curve (AUC) value for predicting low-eGFR.

Conclusion: WWI is the best obesity indicator to predict CKD and albuminuria compared to other obesity indicators (BMI, WHTR, WC, height, and weight). WWI and CKD and albuminuria were found to be positively correlated. Furthermore, height had the strongest ability to predict low-eGFR. Therefore, the importance of WWI and height in assessing kidney health in US adults should be emphasized.

Citing Articles

Curvilinear association between Framingham Steatosis Index and chronic kidney disease: a nationwide cross-sectional study.

Jiang C, Wang B, Wang J, Qu Y, Zhang X Front Med (Lausanne). 2025; 11:1518202.

PMID: 39876873 PMC: 11772482. DOI: 10.3389/fmed.2024.1518202.


Correlation between weight-adjusted waist index and coronary heart disease: NHANES 1999-2020.

Liu Y, Sun S, Zou Q, Tao T, Li D, Han G Front Cardiovasc Med. 2025; 11():1445802.

PMID: 39866803 PMC: 11758883. DOI: 10.3389/fcvm.2024.1445802.


Association between sarcopenia and weight-adjusted waist index in male patients with type 2 diabetes.

Xiang Y, Wang Z, Xu J, Wang J, Wu C, Pan Y BMC Endocr Disord. 2025; 25(1):20.

PMID: 39863834 PMC: 11765918. DOI: 10.1186/s12902-025-01846-y.


Weight-Adjusted Waist Index (WWI)-A Promising Anthropometric Indicator of Depressive Symptoms in Hospitalized Older Patients.

Korycka-Bloch R, Balicki P, Guligowska A, Soltysik B, Kostka T, Chrzastek Z Nutrients. 2025; 17(1.

PMID: 39796502 PMC: 11722845. DOI: 10.3390/nu17010068.


Correlation of the weight-adjusted waist circumference index with Klotho in the United States: differences by sex.

Yin H, Qiu Y, Guo L, Zhu W, Li W, Zhou Y Sci Rep. 2024; 14(1):31118.

PMID: 39732752 PMC: 11682226. DOI: 10.1038/s41598-024-82388-6.


References
1.
Kim J, Choi J, Vella C, Criqui M, Allison M, Kim N . Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis. Diabetes Metab J. 2022; 46(5):747-755. PMC: 9532169. DOI: 10.4093/dmj.2021.0294. View

2.
Piche M, Poirier P, Lemieux I, Despres J . Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018; 61(2):103-113. DOI: 10.1016/j.pcad.2018.06.004. View

3.
Brennan E, Kantharidis P, Cooper M, Godson C . Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021; 17(11):725-739. PMC: 8287849. DOI: 10.1038/s41581-021-00454-y. View

4.
Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... Hypertension. 2017; 71(6):e13-e115. DOI: 10.1161/HYP.0000000000000065. View

5.
Thomas E, Frost G, Taylor-Robinson S, Bell J . Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012; 25(1):150-61. DOI: 10.1017/S0954422412000054. View